Dr George Follows discusses the role of patients in aiding access to new medicines.

The current financial climate and the arrival of expensive long term novel therapies to treat CLL is causing much debate about what government can afford. What can we do to make sure treatments that CLL patients need are available?

This page was last reviewed 22nd October 2019. Next review October 2022

Send us feedback about this page

Send us feedback about this page

Help us to ensure we deliver the best content we can by giving us feedback about this page, good or bad. Please provide an email address if you would like us to respond to your feedback.

"*" indicates required fields